Hematopoietic growth factors. A promising future for use in bone marrow dysfunction.
The clinical future of hematopoietic growth factors appears promising. They will probably achieve broad clinical application in a wide variety of hematologic disorders. Their use in infectious diseases associated with granulocytopenia and in cancer-treatment regimens as adjuvant agents against myelosuppression and perhaps as stimulants of the natural anti-cancer effects of host cells also seems appropriate.
Mazza
J J
JJ
Marshfield Clinic, WI 54449.
Reding
D J
DJ
Plank
G S
GS
D000380:Agranulocytosis / Q000188:drug therapy; D000740:Anemia / Q000188:drug therapy; D001855:Bone Marrow Diseases / Q000188:drug therapy*; D016298:Hematopoietic Cell Growth Factors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy
D016298:Hematopoietic Cell Growth Factors